Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Blood

• Publication date

  2001-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1182/BLOOD.V97.5.1227PMID 11222364
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Osteogenesis imperfecta: A clinical study of the first ten years of life

  2004cited by this paper
• The Chemotherapy Source Book

  2001cited by this paper
• The Metabolic and Molecular Bases of Inherited Disease

  2001cited by this paper
• Pamidronate treatment of severe osteogenesis imperfecta in children under 3 years of age.

  2000cited by this paper
• Effects of allogeneic bone marrow transplantation on recipient bone mineral density: A prospective study.

  2000cited by this paper
• Suppressed Bone Turnover by Bisphosphonates Increases Microdamage Accumulation and Reduces Some Biomechanical Properties in Dog Rib

  2000cited by this paper
• Do More Highly Organized Collagen Fibrils Increase Bone Mechanical Strength in Loss of Mineral Density After One‐Year Running Training?

  1999cited by this paper
• Multilineage potential of adult human mesenchymal stem cells.

  1999cited by this paper
• Collagen and Bone Strength

  1999cited by this paper
• Mechanisms of Bone Loss Following Allogeneic and Autologous Hemopoietic Stem Cell Transplantation

  1999cited by this paper
• Cells Capable of Bone Production Engraft from Whole Bone Marrow Transplants in Nonablated Mice

  1999cited by this paper
• Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta

  1999cited by this paper
• Multipotential cells in the bone marrow stroma: regulation in the context of organ physiology.

  1999cited by this paper
• Dystrophin expression in the mdx mouse restored by stem cell transplantation

  1999cited by this paper
• Bisphosphonates in Children with Osteogenesis Imperfecta may Improve Bone Mineralization but not Bone Strength. Report of Two Patients

  1999cited by this paper
• Muscle regeneration by bone marrow-derived myogenic progenitors.

  1998cited by this paper
• Cyclic administration of pamidronate in children with severe osteogenesis imperfecta.

  1998cited by this paper
• Marrow stromal cells as a source of progenitor cells for nonhematopoietic tissues in transgenic mice with a phenotype of osteogenesis imperfecta.

  1998cited by this paper
• Intravenous pamidronate treatment in osteogenesis imperfecta.

  1998cited by this paper
• Bone mineral density in patients undergoing bone marrow transplantation for myeloid malignancies

  1998cited by this paper
• Postnatal development of bone mineral status during infancy.

  1998cited by this paper
• Intravenous pamidronate treatment in osteogenesis imperfecta.

  1997cited by this paper
• Osteogenesis imperfecta. Rehabilitation and prospects for gene therapy.

  1997cited by this paper
• Principles of Bone Biology

  1996cited by this paper
• Bone mineral disorders in children: evaluation with dual x-ray absorptiometry.

  1995cited by this paper
• Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice.

  1995cited by this paper
• Cellular expression of bone‐related proteins during in vitro osteogenesis in rat bone marrow stromal cell cultures

  1994cited by this paper
• Induction of rapid osteoblast differentiation in rat bone marrow stromal cell cultures by dexamethasone and BMP-2.

  1994cited by this paper
• Busulfan disposition: the role of therapeutic monitoring in bone marrow transplantation induction regimens.

  1993cited by this paper
• Evaluation of growth hormone axis and responsiveness to growth stimulation of short children with osteogenesis imperfecta.

  1993cited by this paper
• Culture‐expanded human periosteal‐derived cells exhibit osteochondral potential in vivo

  1991cited by this paper
• Principles and Practice of Medical Genetics

  1990cited by this paper
• High-dose busulfan and cyclophosphamide with autologous bone marrow transplantation support in advanced malignancies in children: a phase II study.

  1986cited by this paper
• Growth and development following marrow transplantation for leukemia.

  1986cited by this paper
• PRETRANSPLANT CONDITIONING WITH BUSULFAN (MYLERAN) AND CYCLOPHOSPHAMIDE FOR NONMALIGNANT DISEASES: ASSESSMENT OF ENGRAFTMENT FOLLOWING HISTOCOMPATIBLE ALLOGENEIC BONE MARROW TRANSPLANTATION

  1985cited by this paper
• Physical growth: National Center for Health Statistics percentiles.

  1979cited by this paper
• Prolongation of skin allograft survival in lymphocyte-depleted mice.

  1970cited by this paper

• A New Perspective on Osteogenesis Imperfecta: From Cellular Mechanisms to the Systemic Impact of Collagen Dysfunction

  2026cites this paper
• Evolution in Bone Tissue Regeneration: From Grafts to Innovative Biomaterials

  2025cites this paper
• Mesenchymal Stem Cell Transplantation for Osteogenesis Imperfecta Patients: A Systematic Review

  2025cites this paper
• Evaluation of safety and efficacy of multiple intravenous and intraosseous doses of foetal liver-derived mesenchymal stem cells in children with severe osteogenesis imperfecta

  2025cites this paper
• Comprehensive Review of Osteogenesis Imperfecta: Current Treatments and Future Innovations

  2025cites this paper
• The Role of Mitochondrial Homeostasis in Mesenchymal Stem Cell Therapy—Potential Implications in the Treatment of Osteogenesis Imperfecta

  2024cites this paper
• Emerging Landscape of Osteogenesis Imperfecta Pathogenesis and Therapeutic Approaches.

  2024cites this paper
• Bone Quality and Mineralization and Effects of Treatment in Osteogenesis Imperfecta

  2024cites this paper
• New Perspectives of Therapies in Osteogenesis Imperfecta—A Literature Review

  2024cites this paper
• Molecular Biomarkers in Perthes Disease: A Review

  2023cites this paper
• Human Mesenchymal Stem Cells and Innovative Scaffolds for Bone Tissue Engineering Applications

  2023influential citation
• Mesenchymal stem cells in the treatment of osteogenesis imperfecta

  2023cites this paper
• Bone Marrow Stromal Cells Sorted by Semiconducting Polymer Nanodots for Bone Repair.

  2023cites this paper
• Innovations in cell therapy in pediatric diseases: a narrative review

  2023cites this paper
• Enzyme‐Cleaved Bone Marrow Transplantation Improves the Engraftment of Bone Marrow Mesenchymal Stem Cells

  2023cites this paper
• Mesenchymal Stromal Cells for Enhancing Hematopoietic Engraftment and Treatment of Graft-Versus-Host Disease, Hemorrhages and Acute Respiratory Distress Syndrome

  2022cites this paper
• Mesenchymal Stem Cell Therapeutic Potential in Regenerative Medicine and Its Future Direction

  2022cites this paper
• Murine Animal Models in Osteogenesis Imperfecta: The Quest for Improving the Quality of Life

  2022cites this paper
• Recent developments in osteogenesis imperfecta [version 1; peer review: 3 approved]

  2022cites this paper
• Osteogenesis Imperfecta Type 3 in a 10-Year-Old Child With Acute Respiratory Distress Syndrome

  2022cites this paper
• A systematic review and meta-analysis on the efficacy of stem cell therapy on bone brittleness in mouse models of osteogenesis imperfecta

  2021cites this paper
• The Effect of Co-treating Human Mesenchymal Stem Cells with Epigallocatechin Gallate and Hypoxia-Inducible Factor-1 on the Expression of RANKL/RANK/OPG Signaling Pathway, Osteogenesis, and Angiogenesis Genes

  2021cites this paper
• Immunophenotypic Characterization and Therapeutics Effects of Human Bone Marrow- and Umbilical Cord-derived Mesenchymal Stromal Cells in an Experimental Model of Sepsis.

  2021cites this paper
• Review of the Latest Methods of Epidermolysis Bullosa and Other Chronic Wounds Treatment Including BIOOPA Dressing

  2021cites this paper
• Mesencyhmal Stem Cell Therapy for Osteogenesis Imperfect.

  2021cites this paper
• The Progress of Stem Cell Technology for Skeletal Regeneration

  2021cites this paper
• Mesenchymal stem cells in the treatment of osteonecrosis of the jaw

  2021cites this paper
• The skeletal stem cell

  2021cites this paper
• Modification of COL1A1 in Autologous Adipose Tissue‐Derived Progenitor Cells Rescues the Bone Phenotype in a Mouse Model of Osteogenesis Imperfecta

  2021cites this paper
• Review of the Latest Methods in the Treatment of Epidermolysis Bullosa and Other Chronic Wounds, Development of Innovative Advanced Therapy Medicinal Product

  2021cites this paper
• Efeito da terapia celular com células-tronco mesenquimais da medula óssea e do tecido adiposo na regeneração do tecido ósseo

  2021cites this paper
• Enhancing Cystic Fibrosis Immune Regulation

  2021cites this paper
• Avaliação da combinação de injeções locais de células-tronco mesenquimais da medula óssea e do tecido adiposo na regeneração de defeitos ósseos de calvária de ratos

  2021cites this paper
• Surgical Treatment of Wounds Using Stem Cells in Epidermolysis Bullosa (EB)

  2021cites this paper
• Hematopoietic stem cell‐derived functional osteoblasts exhibit therapeutic efficacy in a murine model of osteogenesis imperfecta

  2020cites this paper
• Failures of Endochondral Ossification in the Mucopolysaccharidoses

  2020cites this paper
• Management of Osteogenesis Imperfecta: A Multidisciplinary Comprehensive Approach

  2020cites this paper
• Clinical Application of Bone Marrow Mesenchymal Stem/Stromal Cells to Repair Skeletal Tissue

  2020cites this paper
• A Novel Synthetic, Xeno‐Free Biomimetic Surface for Serum‐Free Expansion of Human Mesenchymal Stromal Cells

  2020cites this paper
• Stem Cell Therapy as a Treatment for Osteogenesis Imperfecta

  2020cites this paper
• Longtime Outcome After Intraosseous Application of Autologous Mesenchymal Stromal Cells in Pediatric Patients and Young Adults with Avascular Necrosis After Steroid or Chemotherapy

  2020cites this paper
• Management of Osteogenesis Imperfecta

  2020cites this paper
• Dissolvable Gelatin‐Based Microcarriers Generated through Droplet Microfluidics for Expansion and Culture of Mesenchymal Stromal Cells

  2020cites this paper
• Adult Stem Cells for Bone Regeneration and Repair

  2019cites this paper
• Stem Cell Regenerative Medicine (SCRM)-A New Hope in Orthopedics-Review Article

  2019cites this paper
• Mesenchymal stem cells in allergic diseases: Current status.

  2019cites this paper
• Cell Therapy: Effect of Locally Injected Mesenchymal Stromal Cells Derived from Bone Marrow or Adipose Tissue on Bone Regeneration of Rat Calvarial Defects

  2019cites this paper
• Stem Cell Transplantation: Clinical Potential in Treating Fetal Genetic Disease

  2019cites this paper
• Advanced cell culture platforms: a growing quest for emulating natural tissues

  2019cites this paper
• Use of Mesenchymal Stem/Stromal Cells for Pediatric Orthopedic Applications

  2019cites this paper
• Engraftment of skeletal progenitor cells by bone‐directed transplantation improves osteogenesis imperfecta murine bone phenotype

  2019cites this paper
• Bone Marrow Transplantation for Treatment of the Col1a2+/G610C Osteogenesis Imperfecta Mouse Model

  2018cites this paper
• Heritable Skeletal Disorders Arising from Defects in Processing and Transport of Type I Procollagen from the ER: Perspectives on Possible Therapeutic Approaches.

  2018cites this paper
• Review ArticleMesenchymal Stem Cells and Orthopaedics (A Current Concept)

  2018cites this paper
• Isolation of rabbit bone marrow mesenchymal stem cells and differentiontion into bone, cartilage, and adipose cell lineages

  2018cites this paper
• Transplanted interleukin-4--secreting mesenchymal stromal cells show extended survival and increased bone mineral density in the murine femur.

  2018cites this paper
• Mesenchymal stromal cells for treatment of the acute respiratory distress syndrome : The beginning of the

  2018cites this paper
• Mesenchymal Stem Cell Therapy for Bone Regeneration

  2018cites this paper
• Epiphyseal growth plate architecture is unaffected by early postnatal activation of the expression of R992C collagen II mutant.

  2018cites this paper
• Changes in phenotype and differentiation potential of human mesenchymal stem cells aging in vitro

  2018cites this paper
• Autologous Mesenchymal Stroma Cells Are Superior to Allogeneic Ones in Bone Defect Regeneration

  2018cites this paper
• Spheroid Culture of Mesenchymal Stromal Cells Results in Morphorheological Properties Appropriate for Improved Microcirculation

  2018cites this paper
• New diagnostic modalities and emerging treatments for neonatal bone disease.

  2018cites this paper
• The Molecular Basis of Genetic Collagen Disorders and Its Clinical Relevance.

  2018cites this paper
• Treatment with neridronate in children and adolescents with osteogenesis imperfecta: Data from open-label, not controlled, three-year Italian study.

  2017cites this paper
• Role of Stem Cells in Orthopaedic Surgery: Theoretical Survey

  2017cites this paper
• Analysis of phenotype reversibility in Hutchinson-Gilford progeria syndrome in mice

  2017cites this paper
• Thymus-Derived Mesenchymal Stem Cells for Tissue Engineering Clinical-Grade Cardiovascular Grafts

  2017cites this paper
• Prospects and limitations of improving skeletal growth in a mouse model of spondyloepiphyseal dysplasia caused by R992C (p.R1192C) substitution in collagen II

  2017cites this paper
• Therapies for genetic extracellular matrix diseases of the skin.

  2017cites this paper
• In Vivo Tracking of Chemokine Receptor CXCR4-Engineered Mesenchymal Stem Cell Migration by Optical Molecular Imaging

  2017cites this paper
• Concise Review: Musculoskeletal Stem Cells to Treat Age‐Related Osteoporosis

  2017cites this paper
• Role of Mesenchymal Stem Cells in Bone Regenerative Medicine: What Is the Evidence?

  2017cites this paper
• Pharmacological targeting of bone marrow mesenchymal stromal/stem cells for the treatment of hematological disorders

  2017cites this paper
• Mesenchymal stem cells in regenerative medicine: a new paradigm for degenerative bone diseases.

  2017cites this paper
• Long-term Effects of Neridronate in Adults with Osteogenesis Imperfecta: An Observational Three-Year Italian Study

  2017cites this paper
• Osteogenesis Imperfecta

  2017cites this paper
• Biotechnological and biomedical applications of mesenchymal stem cells as a therapeutic system

  2016cites this paper
• Stem Cell Therapy for Epidermolysis Bullosa-Does It Work?

  2016cites this paper
• Human Foetal Mesenchymal Stem Cells.

  2016cites this paper
• Mesenchymal stem cells (MSCs) as skeletal therapeutics–an update

  2016cites this paper
• Conditioned umbilical cord tissue provides a natural three-dimensional storage compartment as in vitro stem cell niche for human mesenchymal stroma/stem cells

  2016cites this paper
• Modulation of osteogenic differentiation in mesenchymal stromal cells

  2016cites this paper
• Mesenchymal stem/stromal cell therapy

  2016cites this paper
• Deep tissue single cell MSC ablation using a fiber laser source to evaluate therapeutic potential in osteogenesis imperfecta

  2016cites this paper
• Open Peer Review

  2016cites this paper
• Clinical Trials with Mesenchymal Stem Cells: An Update

  2016cites this paper
• Bone Material Properties in Osteogenesis Imperfecta

  2016cites this paper
• Isolation, expansion and characterisation of mesenchymal stem cells from osteoarthritic and osteoporotic donors

  2016cites this paper
• Bone marrow-derived mesenchymal stem cells (MSCs) stimulate neurite outgrowth from differentiating adult hippocampal progenitor cells

  2016cites this paper
• Implications of mesenchymal stem cells in regenerative medicine

  2016cites this paper
• Ex Vivo Expanded Allogeneic Mesenchymal Stem Cells with Bone Marrow Transplantation Improved Osteogenesis in Infants with Severe Hypophosphatasia

  2015cites this paper
• Bone transplantation and tissue engineering, part IV. Mesenchymal stem cells: history in orthopedic surgery from Cohnheim and Goujon to the Nobel Prize of Yamanaka

  2015cites this paper
• Systemic mesenchymal stem cell administration enhances bone formation in fracture repair but not load-induced bone formation.

  2015cites this paper
• Bone tissue engineering using mesenchymal stem cells

  2015cites this paper
• New frontiers for dominant osteogenesis imperfecta treatment: gene/cellular therapy approaches

  2015cites this paper
• MESENCHYMAL STEM CELLS AND SOLID ORGAN TRANSPLANTATION

  2015cites this paper
• The Current Role of Stem Cells in Orthopaedic Surgery

  2015cites this paper
• Osteogénesis imperfecta en niños y uso de bifosfonatos

  2015cites this paper
• Tethering of Epidermal Growth Factor (EGF) to Beta Tricalcium Phosphate (βTCP) via Fusion to a High Affinity, Multimeric βTCP-Binding Peptide: Effects on Human Multipotent Stromal Cells/Connective Tissue Progenitors

  2015cites this paper